Publications by the researcher in collaboration with Rubén Andújar Espinosa (9)

2025

  1. Efficacy of tezepelumab in patients with severe allergic asthma in clinical practice

    Allergologia et Immunopathologia, Vol. 53, Núm. 5, pp. 193-196

  2. Real-life effectiveness of tezepelumab in severe asthma

    Allergologia et immunopathologia, Vol. 53, Núm. 2, pp. 163-173

  3. Tezepelumab in Patients With Severe Asthma: Response at 3 Months

    Journal of investigational allergology & clinical immunology, Vol. 35, Núm. 2, pp. 132-134

2024

  1. Effectiveness of Mepolizumab in Patients with Severe Eosinophilic Asthma with/without Nasal Polyposis: A Real-Life Study

    International Archives of Allergy and Immunology, Vol. 185, Núm. 3, pp. 253-259

2023

  1. Early Effectiveness of Dupilumab in Patients With Type 2 Severe Asthma: A Prospective Real-Life Study

    Journal of investigational allergology & clinical immunology, Vol. 33, Núm. 2, pp. 126-128

2022

  1. Analysis of response of severe eosinophilic asthmatic patients to benralizumab

    Allergologia et Immunopathologia, Vol. 50, Núm. 6, pp. 163-168

  2. Effectiveness of Benralizumab in Severe Eosinophilic Asthma Under Conditions of Routine Clinical Practice

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 3, pp. 220-223

  3. [Translated article] FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 5, pp. T442-T443

2021

  1. FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study

    Archivos de Bronconeumologia